A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Clinical trial NCT01067105 · COMPLETED

Trial details

NCT number: NCT01067105
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Perennial Allergic Rhinitis

Start date: 2010-02-01
Primary completion: 2010-11-01
Enrollment: 824

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.